We are live on ! Find out more
ADPT icon

Adaptive Biotechnologies
ADPT

111 hedge funds and large institutions have $3.74B invested in Adaptive Biotechnologies in 2019 Q2 according to their latest regulatory filings, with 111 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

64.67% more ownership

Funds ownership: 0% → 64.67% (+65%)

Holders
111
Holders Change
+111
Holders Change %
–
% of All Funds
2.41%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
% of All Funds
0.09%
New
111
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Viking Global Investors
Viking Global Investors
Connecticut
+$1.7B
2
MCMC
Matrix Capital Management Company
New Hampshire
+$768M
3
SIG
Senator Investment Group
New York
+$227M
4
BBA
Baker Bros. Advisors
New York
+$51.6M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$39.9M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Janus Henderson Group
26
Janus Henderson Group
United Kingdom
$12M +$11M +248,900 New
GAMA
27
Graticule Asia Macro Advisors
New York
$11.5M +$10.6M +238,791 New
Citadel Advisors
28
Citadel Advisors
Florida
$11.3M +$10.4M +234,371 New
Invesco
29
Invesco
Georgia
$10.9M +$9.97M +225,000 New
Allianz Asset Management
30
Allianz Asset Management
Germany
$9.84M +$9.03M +203,805 New
AG
31
Artal Group
Luxembourg
$9.66M +$8.86M +200,000 New
ACA
32
Avoro Capital Advisors
New York
$9.66M +$8.86M +200,000 New
Vanguard Group
33
Vanguard Group
Pennsylvania
$9.66M +$8.86M +200,000 New
MWNA
34
Marshall Wace North America
New York
$9.64M +$8.84M +199,500 New
American Century Companies
35
American Century Companies
Missouri
$8.55M +$7.85M +177,091 New
Ameriprise
36
Ameriprise
Minnesota
$7.76M +$7.11M +160,597 New
Fidelity International
37
Fidelity International
Bermuda
$7.69M +$7.06M +159,296 New
Goldman Sachs
38
Goldman Sachs
New York
$7.35M +$6.74M +152,129 New
Morgan Stanley
39
Morgan Stanley
New York
$7.3M +$6.69M +151,087 New
ACH
40
ArrowMark Colorado Holdings
Colorado
$7.25M +$6.64M +150,000 New
LCM
41
Laurion Capital Management
New York
$7.25M +$6.64M +150,000 New
MIM
42
Monashee Investment Management
Massachusetts
$7M +$6.42M +145,000 New
HCM
43
Highline Capital Management
New York
$5.84M +$5.36M +121,000 New
HM
44
HealthCor Management
New York
$5.8M +$5.32M +120,000 New
O
45
OrbiMed
New York
$5.8M +$5.32M +120,000 New
SSA
46
Schonfeld Strategic Advisors
New York
$5.64M +$5.18M +116,845 New
KCM
47
Kingdon Capital Management
New York
$5.55M +$5.09M +115,000 New
Wells Fargo
48
Wells Fargo
California
$5.06M +$4.64M +104,799 New
Adage Capital Partners
49
Adage Capital Partners
Massachusetts
$4.83M +$4.43M +100,000 New
SC
50
Shellback Capital
Massachusetts
$4.83M +$4.43M +100,000 New
1
2
3 4 5

ADPT Hedge Fund Activity: Q2 2019 in Review

111 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Adaptive Biotechnologies (ADPT) for Q2 2019, worth a combined $3.74B.

Buyers outnumbered sellers: 111 funds opened new ADPT positions and 0 closed out — a net gain of 111 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $1.7B.

  • 111 institutional investors held Adaptive Biotechnologies (ADPT) as of Q2 2019, up from 0 in Q1 2019.
  • Funds reported $3.74B of Adaptive Biotechnologies stock for Q2 2019.
  • 111 funds opened new Adaptive Biotechnologies positions in Q2 2019 and 0 closed out, a net change of +111 holders.
  • The largest Adaptive Biotechnologies buyer in Q2 2019 was Viking Global Investors, an estimated $1.7B added.

Based on aggregated 13F filings for Q2 2019.